Physicochemical Properties
| Molecular Formula | C??H??F?N?O?? |
| Molecular Weight | 504.37 |
| Related CAS # | α2β1 Integrin Ligand Peptide;134580-64-6 |
| Appearance | White to off-white solid powder |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture and light. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | α2β1 Integrin Ligand Peptide (DGEA) TFA (0.015-2.0 mM) has no effect on CRW-8 infectivity but suppresses SA11, RRV, and Wa infection in a dose-dependent manner [1]. At doses ≥0.5 mM, α2β1 Integrin Ligand Peptide TFA causes calcium mobilization in osteoblasts and fibroblasts in a tyrosine kinase-dependent manner [1]. At 1.0 mM, α2β1 Integrin Ligand Peptide TFA can no longer prevent SA11 binding [1]. |
| References | [1]. Graham KL, et al. Effects on rotavirus cell binding and infection of monomeric and polymeric peptides containing alpha2beta1 and alphaxbeta2 integrin ligand sequences. J Virol. 2004 Nov;78(21):11786-97. |
Solubility Data
| Solubility (In Vitro) | May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples |
| Solubility (In Vivo) |
Solubility in Formulation 1: 20 mg/mL (39.65 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 1.9827 mL | 9.9134 mL | 19.8267 mL | |
| 5 mM | 0.3965 mL | 1.9827 mL | 3.9653 mL | |
| 10 mM | 0.1983 mL | 0.9913 mL | 1.9827 mL |